(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on Congress’ passage of the Bipartisan Infrastructure Package:
“We applaud Congress for passing the infrastructure legislation, which, when signed into law, will enact a three-year delay of the Medicare Part D rebate rule. There is no question that the rebate rule, if implemented, would unravel the proven success and stability of the Medicare prescription drug program by significantly increasing beneficiary premiums and taxpayer costs.
“We are also encouraged by the inclusion of a permanent repeal of the rebate rule in the current budget reconciliation legislation. It is crucially important that Congress does not undo the progress made by eliminating the rebate rule by including policies in the budget bill that would increase premiums on Medicare beneficiaries.
We look forward to working with Congress and the Administration on policies to lower prescription drug costs and premiums for patients.”
###
PCMA is the national association representing America’s pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, Medicaid plans, and others.
